Efficient Transfection of Large Plasmids Encoding HIV-1 into Human Cells-A High Potential Transfection System Based on a Peptide Mimicking Cationic Lipid.
HIV
cationic lipids
gene therapy
large plasmids
membrane fusion
transfection
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
25 Aug 2020
25 Aug 2020
Historique:
received:
22
07
2020
revised:
20
08
2020
accepted:
20
08
2020
entrez:
29
8
2020
pubmed:
29
8
2020
medline:
29
8
2020
Statut:
epublish
Résumé
One major disadvantage of nucleic acid delivery systems is the low transfection or transduction efficiency of large-sized plasmids into cells. In this communication, we demonstrate the efficient transfection of a 15.5 kb green fluorescent protein (GFP)-fused HIV-1 molecular clone with a nucleic acid delivery system prepared from the highly potent peptide-mimicking cationic lipid OH4 in a mixture with the phospholipid DOPE (co-lipid). For the transfection, liposomes were loaded using a large-sized plasmid (15.5 kb), which encodes a replication-competent HIV type 1 molecular clone that carries a Gag-internal green fluorescent protein (HIV-1 JR-FL Gag-iGFP). The particle size and charge of the generated nanocarriers with 15.5 kb were compared to those of a standardized 4.7 kb plasmid formulation. Stable, small-sized lipoplexes could be generated independently of the length of the used DNA. The transfer of fluorescently labeled pDNA-HIV1-Gag-iGFP in HEK293T cells was monitored using confocal laser scanning microscopy (cLSM). After efficient plasmid delivery, virus particles were detectable as budding structures on the plasma membrane. Moreover, we observed a randomized distribution of fluorescently labeled lipids over the plasma membrane. Obviously, a significant exchange of lipids between the drug delivery system and the cellular membranes occurs, which hints toward a fusion process. The mechanism of membrane fusion for the internalization of lipid-based drug delivery systems into cells is still a frequently discussed topic.
Identifiants
pubmed: 32854383
pii: pharmaceutics12090805
doi: 10.3390/pharmaceutics12090805
pmc: PMC7559901
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Peter und Traudl Engelhorn Stiftung
ID : stipendium
Références
Nucleic Acids Res. 1999 Oct 1;27(19):3792-8
pubmed: 10481017
Sci Rep. 2015 Nov 09;5:16559
pubmed: 26548331
J Virol. 2007 Nov;81(22):12596-607
pubmed: 17728233
J Membr Biol. 2002 Oct 1;189(3):167-79
pubmed: 12395282
Eur J Pharm Biopharm. 2017 Sep;118:38-47
pubmed: 27993732
Biochim Biophys Acta. 2002 Feb 18;1560(1-2):25-36
pubmed: 11958773
Nat Rev Genet. 2014 Aug;15(8):541-55
pubmed: 25022906
AAPS PharmSciTech. 2018 Nov;19(8):3550-3560
pubmed: 30187446
J Control Release. 2015 Dec 28;220(Pt A):295-307
pubmed: 26518724
Int J Pharm. 2014 Jan 1;459(1-2):70-83
pubmed: 24286924
Nat Rev Genet. 2006 Apr;7(4):261-76
pubmed: 16543931
Nat Biotechnol. 2015 Mar;33(3):217-8
pubmed: 25748892
AAPS PharmSciTech. 2019 Jan 7;20(2):50
pubmed: 30617637
Mol Ther. 2005 May;11(5):801-10
pubmed: 15851018
Mol Ther. 2015 Feb;23(2):217-8
pubmed: 25633169
Gene Ther. 2001 Sep;8(18):1387-94
pubmed: 11571578
Nat Biotechnol. 2014 Apr;32(4):347-55
pubmed: 24584096
J Control Release. 2017 Nov 28;266:17-26
pubmed: 28911805
Nat Biotechnol. 2016 Mar;34(3):328-33
pubmed: 26829318
J Virol. 2007 Nov;81(22):12582-95
pubmed: 17728240
Expert Opin Biol Ther. 2005 Jan;5(1):33-53
pubmed: 15709908
Annu Rev Biomed Eng. 2015;17:63-89
pubmed: 26643018
Soft Matter. 2016 Jul 6;12(27):5854-66
pubmed: 27328379
AIDS Res Hum Retroviruses. 2014 Oct;30(10):945-6
pubmed: 25172012
Nat Rev Genet. 2011 May;12(5):316-28
pubmed: 21468099
AIDS Res Hum Retroviruses. 2015 Jun;31(6):579-80
pubmed: 25870000